Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report

A tumor model using human squamous cell carcinoma of the cervix implanted in nude mice was developed. Hydroxyurea and Adriamycin were used as radiopotentiators. A regression delay was observed in tumors treated with radiation therapy alone and radiation therapy and Hydroxyurea. No regression delay w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 1980-04, Vol.9 (2), p.170-176
Hauptverfasser: Xynos, Francisco P., Benjamin, Ivy, Sapiente, Ronald, Rana, M.Waheed, Nalesnik, William J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 176
container_issue 2
container_start_page 170
container_title Gynecologic oncology
container_volume 9
creator Xynos, Francisco P.
Benjamin, Ivy
Sapiente, Ronald
Rana, M.Waheed
Nalesnik, William J.
description A tumor model using human squamous cell carcinoma of the cervix implanted in nude mice was developed. Hydroxyurea and Adriamycin were used as radiopotentiators. A regression delay was observed in tumors treated with radiation therapy alone and radiation therapy and Hydroxyurea. No regression delay was observed when the tumors were treated with radiation therapy and Adriamycin. Six weeks after treatment, 75% of the tumors treated with radiation therapy and Adriamycin were not palpable, while all the tumors were present in the group treated with radiation therapy alone and radiation therapy and Hydroxyurea. No difference in tumor response was noted between the group receiving radiation therapy alone and radiation therapy and Hydroxyurea. This preliminary observation shows obvious interaction between Adriamycin and radiation therapy, suggesting radiopotentiating activity. The tumor model was found useful and practical.
doi_str_mv 10.1016/0090-8258(80)90024-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75099144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0090825880900244</els_id><sourcerecordid>75099144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-ce98de22c1d5df12b151980197dfea2892a91876fee4b276fb0c8e8ddb4ca2233</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhkVpSTZp36AFnUpycDuS7bWUQ2AJTVsI9NKehSyNiYplOZIcsi-S563cXXLMaUD_N7_mnyHkI4MvDNj2K4CESvBWXAi4lAC8qZo3ZMNAttVWtPIt2bwgp-Qspb8AUAPjJ-SkqzvOhNyQ552NTvu9cRPVk6X3exvD036JqKlONGrrwhwyTtnpHGKihcv3SHMBsi_PNAw0PSzahyVRg-NIjY7FLXi9SitrMD66J-r8POopo109psUi9c7gFd3ROeLovJt03NOIc4j5PXk36DHhh2M9J39uv_2--VHd_fr-82Z3V5m67XJlUAqLnBtmWzsw3rOWSQFMdnZAzYXkWjLRbQfEpuel9mAECmv7xmjO6_qcfD74zjE8LJiy8i6tKfSEJZDqWpCSNU0BmwNoYkgp4qDm6HwZWDFQ6znUumu17loJUP_Poda2T0f_pfdoX5qO-y_69UHHEvLRYVTJOJwMWhfRZGWDe_2Df8ienXM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75099144</pqid></control><display><type>article</type><title>Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Xynos, Francisco P. ; Benjamin, Ivy ; Sapiente, Ronald ; Rana, M.Waheed ; Nalesnik, William J.</creator><creatorcontrib>Xynos, Francisco P. ; Benjamin, Ivy ; Sapiente, Ronald ; Rana, M.Waheed ; Nalesnik, William J.</creatorcontrib><description>A tumor model using human squamous cell carcinoma of the cervix implanted in nude mice was developed. Hydroxyurea and Adriamycin were used as radiopotentiators. A regression delay was observed in tumors treated with radiation therapy alone and radiation therapy and Hydroxyurea. No regression delay was observed when the tumors were treated with radiation therapy and Adriamycin. Six weeks after treatment, 75% of the tumors treated with radiation therapy and Adriamycin were not palpable, while all the tumors were present in the group treated with radiation therapy alone and radiation therapy and Hydroxyurea. No difference in tumor response was noted between the group receiving radiation therapy alone and radiation therapy and Hydroxyurea. This preliminary observation shows obvious interaction between Adriamycin and radiation therapy, suggesting radiopotentiating activity. The tumor model was found useful and practical.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/0090-8258(80)90024-4</identifier><identifier>PMID: 7372189</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - radiotherapy ; Carcinoma, Squamous Cell - therapy ; Doxorubicin - therapeutic use ; Female ; Humans ; Hydroxyurea - therapeutic use ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Radiation-Sensitizing Agents - therapeutic use ; Uterine Cervical Neoplasms - drug therapy ; Uterine Cervical Neoplasms - radiotherapy ; Uterine Cervical Neoplasms - therapy</subject><ispartof>Gynecologic oncology, 1980-04, Vol.9 (2), p.170-176</ispartof><rights>1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-ce98de22c1d5df12b151980197dfea2892a91876fee4b276fb0c8e8ddb4ca2233</citedby><cites>FETCH-LOGICAL-c357t-ce98de22c1d5df12b151980197dfea2892a91876fee4b276fb0c8e8ddb4ca2233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0090-8258(80)90024-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7372189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xynos, Francisco P.</creatorcontrib><creatorcontrib>Benjamin, Ivy</creatorcontrib><creatorcontrib>Sapiente, Ronald</creatorcontrib><creatorcontrib>Rana, M.Waheed</creatorcontrib><creatorcontrib>Nalesnik, William J.</creatorcontrib><title>Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>A tumor model using human squamous cell carcinoma of the cervix implanted in nude mice was developed. Hydroxyurea and Adriamycin were used as radiopotentiators. A regression delay was observed in tumors treated with radiation therapy alone and radiation therapy and Hydroxyurea. No regression delay was observed when the tumors were treated with radiation therapy and Adriamycin. Six weeks after treatment, 75% of the tumors treated with radiation therapy and Adriamycin were not palpable, while all the tumors were present in the group treated with radiation therapy alone and radiation therapy and Hydroxyurea. No difference in tumor response was noted between the group receiving radiation therapy alone and radiation therapy and Hydroxyurea. This preliminary observation shows obvious interaction between Adriamycin and radiation therapy, suggesting radiopotentiating activity. The tumor model was found useful and practical.</description><subject>Animals</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Doxorubicin - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxyurea - therapeutic use</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Transplantation</subject><subject>Radiation-Sensitizing Agents - therapeutic use</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><subject>Uterine Cervical Neoplasms - therapy</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFq3DAQhkVpSTZp36AFnUpycDuS7bWUQ2AJTVsI9NKehSyNiYplOZIcsi-S563cXXLMaUD_N7_mnyHkI4MvDNj2K4CESvBWXAi4lAC8qZo3ZMNAttVWtPIt2bwgp-Qspb8AUAPjJ-SkqzvOhNyQ552NTvu9cRPVk6X3exvD036JqKlONGrrwhwyTtnpHGKihcv3SHMBsi_PNAw0PSzahyVRg-NIjY7FLXi9SitrMD66J-r8POopo109psUi9c7gFd3ROeLovJt03NOIc4j5PXk36DHhh2M9J39uv_2--VHd_fr-82Z3V5m67XJlUAqLnBtmWzsw3rOWSQFMdnZAzYXkWjLRbQfEpuel9mAECmv7xmjO6_qcfD74zjE8LJiy8i6tKfSEJZDqWpCSNU0BmwNoYkgp4qDm6HwZWDFQ6znUumu17loJUP_Poda2T0f_pfdoX5qO-y_69UHHEvLRYVTJOJwMWhfRZGWDe_2Df8ienXM</recordid><startdate>198004</startdate><enddate>198004</enddate><creator>Xynos, Francisco P.</creator><creator>Benjamin, Ivy</creator><creator>Sapiente, Ronald</creator><creator>Rana, M.Waheed</creator><creator>Nalesnik, William J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198004</creationdate><title>Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report</title><author>Xynos, Francisco P. ; Benjamin, Ivy ; Sapiente, Ronald ; Rana, M.Waheed ; Nalesnik, William J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-ce98de22c1d5df12b151980197dfea2892a91876fee4b276fb0c8e8ddb4ca2233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Animals</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Doxorubicin - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxyurea - therapeutic use</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Transplantation</topic><topic>Radiation-Sensitizing Agents - therapeutic use</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><topic>Uterine Cervical Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xynos, Francisco P.</creatorcontrib><creatorcontrib>Benjamin, Ivy</creatorcontrib><creatorcontrib>Sapiente, Ronald</creatorcontrib><creatorcontrib>Rana, M.Waheed</creatorcontrib><creatorcontrib>Nalesnik, William J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xynos, Francisco P.</au><au>Benjamin, Ivy</au><au>Sapiente, Ronald</au><au>Rana, M.Waheed</au><au>Nalesnik, William J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1980-04</date><risdate>1980</risdate><volume>9</volume><issue>2</issue><spage>170</spage><epage>176</epage><pages>170-176</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>A tumor model using human squamous cell carcinoma of the cervix implanted in nude mice was developed. Hydroxyurea and Adriamycin were used as radiopotentiators. A regression delay was observed in tumors treated with radiation therapy alone and radiation therapy and Hydroxyurea. No regression delay was observed when the tumors were treated with radiation therapy and Adriamycin. Six weeks after treatment, 75% of the tumors treated with radiation therapy and Adriamycin were not palpable, while all the tumors were present in the group treated with radiation therapy alone and radiation therapy and Hydroxyurea. No difference in tumor response was noted between the group receiving radiation therapy alone and radiation therapy and Hydroxyurea. This preliminary observation shows obvious interaction between Adriamycin and radiation therapy, suggesting radiopotentiating activity. The tumor model was found useful and practical.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7372189</pmid><doi>10.1016/0090-8258(80)90024-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-8258
ispartof Gynecologic oncology, 1980-04, Vol.9 (2), p.170-176
issn 0090-8258
1095-6859
language eng
recordid cdi_proquest_miscellaneous_75099144
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Carcinoma, Squamous Cell - drug therapy
Carcinoma, Squamous Cell - radiotherapy
Carcinoma, Squamous Cell - therapy
Doxorubicin - therapeutic use
Female
Humans
Hydroxyurea - therapeutic use
Mice
Mice, Nude
Neoplasm Transplantation
Radiation-Sensitizing Agents - therapeutic use
Uterine Cervical Neoplasms - drug therapy
Uterine Cervical Neoplasms - radiotherapy
Uterine Cervical Neoplasms - therapy
title Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: A preliminary report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adriamycin%20and%20hydroxyurea%20as%20radiopotentiators%20in%20the%20treatment%20of%20squamous%20cell%20carcinoma%20of%20the%20cervix%20implanted%20in%20nude%20mice:%20A%20preliminary%20report&rft.jtitle=Gynecologic%20oncology&rft.au=Xynos,%20Francisco%20P.&rft.date=1980-04&rft.volume=9&rft.issue=2&rft.spage=170&rft.epage=176&rft.pages=170-176&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/0090-8258(80)90024-4&rft_dat=%3Cproquest_cross%3E75099144%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75099144&rft_id=info:pmid/7372189&rft_els_id=0090825880900244&rfr_iscdi=true